Recall of Zantac Solution for Injection
30 September 2019
GSK has made the decision to initiate a voluntary recall (pharmacy/retail level recall) of Zantac products manufactured using API sourced from Saraca Laboratories Limited and Dr Reddy’s Limited as a precautionary action.
This recall affects all dose forms of Zantac products to all markets manufactured using API sourced from Saraca Laboratories Limited and Dr Reddy’s Limited, including Zantac IV (injection) in New Zealand.
This recall action is being taken by GSK NZ after consultation with Medsafe and in line with the New Zealand Medicines and Medical Devices Recall Code procedure.